AIM ImmunoTech Shares Are Trading Higher After the Company Announced the Print Publication of the Data Analysis From Its Early Access Program Studying Ampligen.
AIM ImmunoTech Shares Are Trading Higher After the Company Announced the Print Publication of the Data Analysis From Its Early Access Program Studying Ampligen.
aim immunotech股票價格上漲，該公司宣佈早期接觸項目研究ampelgen的數據分析報告已印刷出版。
AIM ImmunoTech Shares Are Trading Higher After the Company Announced the Print Publication of the Data Analysis From Its Early Access Program Studying Ampligen.
aim immunotech股票價格上漲，該公司宣佈早期接觸項目研究ampelgen的數據分析報告已印刷出版。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。